These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21037516)

  • 1. Pregnancy complicated by plasminogen activator inhibitor type 1 deficiency.
    Smith C; Thornton YS
    South Med J; 2010 Dec; 103(12):1259-60. PubMed ID: 21037516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor type 1 deficiency.
    Mehta R; Shapiro AD
    Haemophilia; 2008 Nov; 14(6):1255-60. PubMed ID: 19141166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum.
    Peitsidis P; Kadir RA
    Expert Opin Pharmacother; 2011 Mar; 12(4):503-16. PubMed ID: 21294602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first report of uncontrollable subchorionic and retroplacental haemorrhage inducing preterm labour in complete PAI-1 deficiency in a human.
    Iwaki T; Nagahashi K; Kobayashi T; Umemura K; Terao T; Kanayama N
    Thromb Res; 2012 Apr; 129(4):e161-3. PubMed ID: 22099705
    [No Abstract]   [Full Text] [Related]  

  • 5. The obstetric, gynaecological and fertility implications of homozygous PAI-1 deficiency: single-centre experience.
    Heiman M; Gupta S; Shapiro AD
    Haemophilia; 2014 May; 20(3):407-12. PubMed ID: 24261743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of the delivery in pregnant women with severe factor XI deficiency.
    Martin-Salces M; Jimenez-Yuste V; Alvarez MT; Quintana M; Hernandez-Navarro F
    Acta Haematol; 2008; 119(3):154-5. PubMed ID: 18434707
    [No Abstract]   [Full Text] [Related]  

  • 7. The obstetric experience of women with factor XI deficiency.
    Chi C; Kulkarni A; Lee CA; Kadir RA
    Acta Obstet Gynecol Scand; 2009; 88(10):1095-100. PubMed ID: 19685354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Occurrence and treatment of a hyperfibrinolytic event after spontaneous delivery].
    Oberheuser F; Goris J; Hörder MH
    Zentralbl Gynakol; 1967 Oct; 89(42):1544-8. PubMed ID: 5301539
    [No Abstract]   [Full Text] [Related]  

  • 9. [Management of blood coagulation disorders].
    Porchia NL
    Matern Infanc (Sao Paulo); 1968; 27(4):349-55. PubMed ID: 5728525
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anesthetic management of a patient with congenital plasminogen activator inhibitor-1 deficiency].
    Kajihara A; Kurehara H; Kitaguchi K; Furuya H; Morimoto Y; Kirita T; Fukuda K; Takahashi Y
    Masui; 2003 Jan; 52(1):73-5. PubMed ID: 12632627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of thromboelastography and tranexamic acid in plasminogen activator inhibitor deficiency during pregnancy: a rare case report.
    Prabhakaran N; Laziuk K; Hammer RD
    Blood Coagul Fibrinolysis; 2020 Jan; 31(1):87-91. PubMed ID: 31743119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Using recombinant activated coagulation factor VII (NovoSeven) in obstetrics].
    Pekhlivanov B; Milchev N; Abrashev B
    Akush Ginekol (Sofiia); 2003; 42(6):7-9. PubMed ID: 15067806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral management of a patient with a plasminogen activator inhibitor (PAI-1) deficiency: case report.
    Tanimura LK; Weddell JA; McKown CG; Shapiro AD; Mulherin J
    Pediatr Dent; 1994; 16(2):133-5. PubMed ID: 8015955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy.
    Coolman M; de Groot CJ; Steegers EA; Geurts-Moespot A; Thomas CM; Steegers-Theunissen RP; Sweep FC
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):22-8. PubMed ID: 16584829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contrykal as antifibrinolytic agent in obstetrics and gynecology].
    Flähmig M; Sieg U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):142-50. PubMed ID: 4174652
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pregnancy and delivery in a case with congenital factor VII deficiency].
    Ota T; Takita K; Yamamoto T; Arai K
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Oct; 34(10):1797-800. PubMed ID: 6983546
    [No Abstract]   [Full Text] [Related]  

  • 17. Life-threatening hemorrhage and prolonged wound healing are remarkable phenotypes manifested by complete plasminogen activator inhibitor-1 deficiency in humans.
    Iwaki T; Tanaka A; Miyawaki Y; Suzuki A; Kobayashi T; Takamatsu J; Matsushita T; Umemura K; Urano T; Kojima T; Terao T; Kanayama N
    J Thromb Haemost; 2011 Jun; 9(6):1200-6. PubMed ID: 21486382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Report of a case of congenital plasminogen activator inhibitor-1 deficiency].
    Zhang ZY; Wang ZY; Fu JX; Dong NZ; Zhang W; Bai X; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2004 Mar; 25(3):129-31. PubMed ID: 15182577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menorrhagia due to a qualitative deficiency of plasminogen activator inhibitor-1: case report and literature review.
    Repine T; Osswald M
    Clin Appl Thromb Hemost; 2004 Jul; 10(3):293-6. PubMed ID: 15247991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraparenchymal hemorrhage in a patient with osteogenesis imperfecta and plasminogen activator inhibitor-1 deficiency.
    Goddeau RP; Caplan LR; Alhazzani AA
    Arch Neurol; 2010 Feb; 67(2):236-8. PubMed ID: 20142533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.